ITGAX and breast cancer: Our results showed that the odds ratio (OR) of CD11c+ HLA-DR++ conventional dendritic cells (cDC) on breast cancer development was estimated to be 1.1295 (OR [95% CI], 1.1295 [1.0632-1.2000], P = 8.044 × 10-5) (Figure 2).